These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20300977)

  • 1. Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer.
    Hu SL; Huang DB; Sun YB; Wu L; Xu WP; Yin S; Chen J; Jiang XD; Shen G
    Med Oncol; 2011 Jun; 28(2):447-54. PubMed ID: 20300977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
    Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
    Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma.
    Gao YJ; Xin Y; Zhang JJ; Zhou J
    World J Gastroenterol; 2008 Aug; 14(32):5000-7. PubMed ID: 18763281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation of CHFR gene in gastric carcinoma tissues detected using two methods.
    Cheng ZD; Hu SL; Sun YB; Xu WP; Shen G; Kong XY
    Chin J Cancer; 2010 Feb; 29(2):163-6. PubMed ID: 20109344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer.
    Hiraki M; Kitajima Y; Sato S; Mitsuno M; Koga Y; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
    Ann Surg Oncol; 2010 Apr; 17(4):1177-86. PubMed ID: 19957042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of CHFR and MLH1 methylation in human gastric cancer.
    Li Y; Yang Y; Lu Y; Herman JG; Brock MV; Zhao P; Guo M
    Gastric Cancer; 2015 Apr; 18(2):280-7. PubMed ID: 24748501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant methylation of the CHFR gene in digestive tract cancer.
    Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
    Anticancer Res; 2006; 26(3A):1791-5. PubMed ID: 16827108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer.
    Cha Y; Kim SY; Yeo HY; Baek JY; Choi MK; Jung KH; Dong SM; Chang HJ
    Neoplasia; 2019 Jan; 21(1):146-155. PubMed ID: 30562637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Runt-related transcription factor 3: single nucleotide polymorphism rs760805, gene expression, and methylation status in Helicobacter pylori -infected patients for determination of gastric cancer risk.
    Nadarajan N; Balasubramanian LK; Kuppannan S; Ramachandran C; Leelakrishnan V
    J Gastrointest Cancer; 2013 Dec; 44(4):444-9. PubMed ID: 23959374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of CpG methylation status of Runx3 with pathogenesis of gastric carcinoma].
    Tang GH; Sun SW; He XS
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):314-9. PubMed ID: 22883670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers.
    Kang HC; Kim IJ; Park JH; Shin Y; Park HW; Ku JL; Yang HK; Lee KU; Choe KJ; Park JG
    Oncol Rep; 2004 Jul; 12(1):129-33. PubMed ID: 15201973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer.
    Hiraki M; Kitajima Y; Sato S; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
    World J Gastroenterol; 2010 Jan; 16(3):330-8. PubMed ID: 20082478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant methylation of heparan sulfate glucosamine 3-O-sulfotransferase 2 genes as a biomarker in colorectal cancer.
    Tokuyama Y; Takahashi T; Okumura N; Nonaka K; Kawaguchi Y; Yamaguchi K; Osada S; Gazdar A; Yoshida K
    Anticancer Res; 2010 Dec; 30(12):4811-8. PubMed ID: 21187457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation of CHFR is not a predictor of the response to docetaxel and paclitaxel in advanced and recurrent gastric cancer.
    Yoshida K; Hamai Y; Suzuki T; Sanada Y; Oue N; Yasui W
    Anticancer Res; 2006; 26(1A):49-54. PubMed ID: 16475678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between promoter methylation of Syk and Runx3 genes and postoperative recurrence and metastasis in gastric carcinoma].
    Hong H; Zhou K; Fu P; Huang Q; Wang J; Yuan X; Li J
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):341-5. PubMed ID: 25030588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer.
    Oki E; Zhao Y; Yoshida R; Masuda T; Ando K; Sugiyama M; Tokunaga E; Morita M; Kakeji Y; Maehara Y
    World J Gastroenterol; 2009 May; 15(20):2520-5. PubMed ID: 19469003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between Runx3 gene expression and its DNA methylation in gastric cancer].
    Gao N; Chen WC; Cen JN
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):361-4. PubMed ID: 18953836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer.
    Koga Y; Kitajima Y; Miyoshi A; Sato K; Sato S; Miyazaki K
    J Gastroenterol; 2006 Feb; 41(2):133-9. PubMed ID: 16568372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.